The Mysterious Human Heart featuring discussants Eric Rose, Elizabeth Nabel and Douglas Zipes. David Grubin moderates.
The beat of the human heart is literally the definition of life, but when the heart malfunctions it is also the leading cause of human illness. How are genetics, molecular biology and imaging reshaping how we define hypertension, heart disease, and stroke? Presented in partnership with AstraZeneca- Aspen Institute
David Grubin is a producer, director, writer, and cinematographer who has won every major award in his field, including three George Foster Peabody awards, two Alfred I. duPont-Columbia University awards, and nine Emmys. As the president of DAVID GRUBIN PRODUCTIONS, INC., Mr. Grubin has produced over 100 films on subjects ranging from history to art, from poetry to science. A member of the executive committee of the Society of American Historians, Grubin has received a Guggenheim Fellowship, has been a Montgomery Fellow at Dartmouth College, and is the recipient of an honorary doctorate from his alma mater, Hamilton College. He is a member of the Directors Guild and the Writers Guild, and serves on the board of directors of the Film Forum. Mr. Grubin is currently producing a three-hour series for PBS, entitled "The Mysterious Human Heart," which is to be premiered at the Aspen Health Forum.
Elizabeth G. Nabel is Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health. Dr. Nabel leads an extensive international research portfolio with an annual budget of about $3 billion to prevent, diagnose, and treat heart, lung, and blood diseases. As a physician-scientist, Dr. Nabel has made substantial contributions to our understanding of the molecular genetics of cardiovascular diseases, which have led to the development of novel therapeutics and devices.
She is the recipient of the Willem Einthoven Award, the Amgen-Scientific Achievement Award, and the American Heart Association Distinguished Achievement Award, as well as several honorary degrees. Dr. Nabel is an elected member of the Institute of Medicine, where she serves on its governing council.
Eric Rose is Executive Vice President for Life Sciences at MacAndrews & Forbes and CEO of Siga Technologies, Inc., a developer of anti-viral drugs directed at potential agents of bioterror. He is on leave from his position as Surgeon in Chief at New York-Presbyterian Hospital/Columbia and Chairman of the Department of Surgery at the Columbia University College of Physicians and Surgeons, where he holds a distinguished professorship. An accomplished heart surgeon, researcher and entrepreneur, Dr. Rose has grown one of the nation's premier departments of surgery over the past 25 years while managing, investigating and developing complex medical technologies such as for heart transplantation and novel approaches to Alzheimer’s disease and bioterrorism.
Dr. Rose pioneered heart transplantation in children, performing the first successful pediatric heart transplant in 1984, and has investigated many alternatives to heart transplantation, including cross-species transplantation and man-made heart pumps. He received his MD from Columbia University.
Douglas P. Zipes is a Distinguished Professor Emeritus at the Indiana University School of Medicine and a past president of both the American College of Cardiology and the Heart Rhythm Society. Dr. Zipes specializes in the research and treatment of cardiac arrhythmias and was a member of the team that developed the first cardioverter, a device that administers electric shock to restore the heart’s normal rhythm. He also pioneered an alcohol ablation catheterization technique, which cures some arrhythmias, and is a specialist on Wolf-Parkinson-White Syndrome, Marfan Syndrome, and sudden death in athletes.
Dr. Zipes has received many awards in recognition of his work, including the Distinguished Achievement Award from the American Heart Association. He was founding editor of the Journal of Cardiovascular Electrophysiology and the new journal of the Heart Rhythm Society. He received his MD from Harvard Medical School and his postgraduate training at Duke University Medical Center.